CCA Industries Total Current Liabilities 2010-2025 | CAWW
CCA Industries total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
CCA Industries Annual Total Current Liabilities
(Millions of US $) |
| 2024 |
$2 |
| 2023 |
$2 |
| 2022 |
$3 |
| 2021 |
$3 |
| 2020 |
$4 |
| 2018 |
$5 |
| 2017 |
$6 |
| 2016 |
$9 |
| 2015 |
$11 |
| 2014 |
$11 |
| 2013 |
$9 |
| 2012 |
$11 |
| 2011 |
$9 |
| 2010 |
$9 |
| 2009 |
$9 |
CCA Industries Quarterly Total Current Liabilities
(Millions of US $) |
| 2025-02-28 |
$2 |
| 2024-11-30 |
$2 |
| 2024-08-31 |
$2 |
| 2024-05-31 |
$2 |
| 2024-02-29 |
$2 |
| 2023-11-30 |
$2 |
| 2023-08-31 |
$3 |
| 2023-05-31 |
$3 |
| 2023-02-28 |
$3 |
| 2022-11-30 |
$3 |
| 2022-08-31 |
$3 |
| 2022-05-31 |
$3 |
| 2022-02-28 |
$3 |
| 2021-11-30 |
$3 |
| 2021-08-31 |
|
| 2021-05-31 |
|
| 2021-02-28 |
|
| 2019-02-28 |
$5 |
| 2018-11-30 |
$5 |
| 2018-08-31 |
$6 |
| 2018-05-31 |
$5 |
| 2018-02-28 |
$5 |
| 2017-11-30 |
$6 |
| 2017-08-31 |
$8 |
| 2017-05-31 |
$9 |
| 2017-02-28 |
$9 |
| 2016-11-30 |
$9 |
| 2016-08-31 |
$10 |
| 2016-05-31 |
$11 |
| 2016-02-29 |
$12 |
| 2015-11-30 |
$11 |
| 2015-08-31 |
$9 |
| 2015-05-31 |
$10 |
| 2015-02-28 |
$12 |
| 2014-11-30 |
$11 |
| 2014-08-31 |
$10 |
| 2014-05-31 |
$14 |
| 2014-02-28 |
$10 |
| 2013-11-30 |
$9 |
| 2013-08-31 |
$10 |
| 2013-05-31 |
$11 |
| 2013-02-28 |
$10 |
| 2012-11-30 |
$11 |
| 2012-08-31 |
$10 |
| 2012-05-31 |
$10 |
| 2012-02-29 |
$11 |
| 2011-11-30 |
$9 |
| 2011-08-31 |
$8 |
| 2011-05-31 |
$9 |
| 2011-02-28 |
$9 |
| 2010-11-30 |
$9 |
| 2010-08-31 |
$11 |
| 2010-05-31 |
$13 |
| 2010-02-28 |
$9 |
| 2009-11-30 |
$9 |
| 2009-08-31 |
$11 |
| 2009-05-31 |
$10 |
| 2009-02-28 |
$12 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Cosmetics and Toiletries |
$0.006B |
$0.008B |
|
CCA INDUSTRIES, INC. is engaged in the health and beauty aids business with a line of health and beauty aids products which it has manufactured on its behalf under its formulations.
|
